Hyungjoo Kim - Search Results

Year	Number of Results
2003	1
2007	1
2010	3
2011	4
2012	2
2013	2
2014	5
2015	2
2016	5
2017	10
2018	10
2019	6
2020	4
2021	11
2022	4
2023	6
2024	8
2025	2
2026	0

1

The acid-sensing receptor GPR65 on tumor macrophages drives tumor growth in obesity.

Bagchi S, Yuan R, Huang HL, Zhang W, Chiu DK, Kim H, Cha SL, Tolentino L, Lowitz J, Liu Y, Moshnikova A, Andreev O, Plevritis S, Engleman EG. Bagchi S, et al. Among authors: kim h. Sci Immunol. 2024 Oct 18;9(100):eadg6453. doi: 10.1126/sciimmunol.adg6453. Epub 2024 Oct 18. Sci Immunol. 2024. PMID: 39423285 Free PMC article.

2

Nidogen-1 suppresses cell proliferation, migration, and glycolysis via integrin β1-mediated HIF-1α downregulation in triple-negative breast cancer.

Lee JH, Son S, Ko Y, Lim H, Lee M, Kang MG, Kim H, Lee KM, Shin I. Lee JH, et al. Among authors: kim h. Sci Rep. 2025 Mar 27;15(1):10633. doi: 10.1038/s41598-024-84880-5. Sci Rep. 2025. PMID: 40148359 Free PMC article.

3

Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance.

Kim H, Choi JM, Lee KM. Kim H, et al. Biomedicines. 2022 May 13;10(5):1130. doi: 10.3390/biomedicines10051130. Biomedicines. 2022. PMID: 35625867 Free PMC article. Review.

4

MHC II immunogenicity shapes the neoepitope landscape in human tumors.

Kim JY, Cha H, Kim K, Sung C, An J, Bang H, Kim H, Yang JO, Chang S, Shin I, Noh SJ, Shin I, Cho DY, Lee SH, Choi JK. Kim JY, et al. Among authors: kim h. Nat Genet. 2023 Feb;55(2):221-231. doi: 10.1038/s41588-022-01273-y. Epub 2023 Jan 9. Nat Genet. 2023. PMID: 36624345

5

CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer.

Son S, Kim H, Lim H, Lee JH, Lee KM, Shin I. Son S, et al. Among authors: kim h. Cell Death Dis. 2023 Feb 3;14(2):81. doi: 10.1038/s41419-023-05608-3. Cell Death Dis. 2023. PMID: 36737605 Free PMC article.

6

Egr-1 is required for neu/HER2-induced mammary tumors.

Oh S, Kim H, Nam K, Shin I. Oh S, et al. Among authors: kim h. Cell Signal. 2018 May;45:102-109. doi: 10.1016/j.cellsig.2018.02.003. Epub 2018 Feb 2. Cell Signal. 2018. PMID: 29408223

7

Recent Advances in Nanomaterials for Modulation of Stem Cell Differentiation and Its Therapeutic Applications.

Kim CD, Koo KM, Kim HJ, Kim TH. Kim CD, et al. Biosensors (Basel). 2024 Aug 22;14(8):407. doi: 10.3390/bios14080407. Biosensors (Basel). 2024. PMID: 39194636 Free PMC article. Review.

8

S-plasty--clinical applications for skin surgery.

Kim P, Kim HJ. Kim P, et al. Aust Fam Physician. 2011 Apr;40(4):224-5. Aust Fam Physician. 2011. PMID: 21597534

9

Epigenetic inactivation of RUNX3 in colorectal cancer.

Shin EJ, Kim HJ, Son MW, Ahn TS, Lee HY, Lim DR, Bae SB, Jeon S, Kim H, Jeong D, Lee MS, Kim DS, Noh JS, Baek MJ. Shin EJ, et al. Among authors: kim h. Ann Surg Treat Res. 2018 Jan;94(1):19-25. doi: 10.4174/astr.2018.94.1.19. Epub 2017 Dec 28. Ann Surg Treat Res. 2018. PMID: 29333422 Free PMC article.

10

Induction of SUSD2 by STAT3 Activation Is Associated with Tumor Recurrence in HER2-Positive Breast Cancer.

Jeong Y, Kim H, You D, Cho SY, Yoon SY, Kim SW, Nam SJ, Lee JE, Kim S. Jeong Y, et al. Among authors: kim h. Cells. 2024 Dec 28;14(1):19. doi: 10.3390/cells14010019. Cells. 2024. PMID: 39791720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year